目的:探讨超声乳化白内障吸除、人工晶状体植入联合小梁切除术治疗白内障合并青光眼的临床疗效及安全性。方法:将100例白内障合并青光眼患者按照抽签法随机地均分为对照组与观察组,对照组给予单纯超声乳化人工晶状体植入术,观察组在此基础上给予联合小梁切除术进行治疗。比较两组治疗前后相关指标以及术后并发症发生率等。结果:(1)对照组治疗前后IOP、ACD及AL均无统计学差异,观察组治疗前后IOP与CAD差异具有统计学意义(P〈0.05,P〈0.01),但该组治疗前后AL无统计学差异;(2)两组术前与术后1周、1个月及3个月平均视野缺损值、平均模式标准差相比,差异均具有统计学意义,且观察组术后与对照组术后相比,差异均具有统计学意义;(3)对照组并发症发生率为20.00%,明显大于观察组(10.00%)。结论:超声乳化白内障吸除、人工晶状体植入联合小梁切除术治疗白内障合并青光眼,疗效显著,不良反应发生率低,值得加以推广并应用。
Objective: To investigate the clinical efficacy and plantation and trabeculectomy on the treatment of cataract combined safety about the additional phaeoemulsification, intraocular lens ira- with glaucoma. Methods: 100 cases of cataract combined with glau- coma who were selected and randomly divided into the control group and the observation group according to the law of draw. Patients of the control group were treated by the simple phacoemulsification and intraocular lens implantation, while the patients in the observation group were given trabeculectomy besides the basic methods. The relative indexes and the average incidence of postoperative complica- tions etc. were compared before and after the treatment. Results: (1) There was no statistically significant difference of the control group before and after treatment in terms of the lOP, ACD and AL; There were statistically signifcant differences in terms of the CAD and lOP in the observation group before and after treatment (P〈0.05); but there was no significant difference about AL before and after treatment. (2) Preoperative and postoperative lweek, 1month and 3month average value of visual field defects, the average pattern standard devia- tion, the differences were statistically significant, and there were statistical difference between the two groups between the two groups. (3) The complication rate in the control group was 20.00%, which was significantly higher than that of the observation group (10.00%). Conclusion: The phacoemulsification, intraocular lens implantation and trabeculectomy of cataract combined with glaucoma has a significant effect, low incidence of adverse reactions, and it is worthy to be promoted and applied clinically.